Delivery Order SPE2DB22D1106-SPE2DB25FDRE6
Award Date 12/18/24
Potential Completion Date 1/10/25
Potential Value $41K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award valued at $16,586.68 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024. The award is for the delivery of Tecentriq 840 mg/14 ml vials, a specialty oncology medication, with a period of performance through January 6, 2025. The contract is a firm fixed-price delivery order and was not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,016.30 firm-fixed-price contract is for the delivery of 840 mg/14 mL vials of the drug Tecentriq, with a performance period through November 2024. This contract award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $21,261.50 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, to provide the specialty medication Tecentriq (840 mg/14 ml vial) under a firm fixed price delivery order. The award has a ceiling value of $16,032.60 and a period of performance through April 4, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,344.66 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials on January 28, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 19, 2026, with performance executed from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,344.66 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials on January 28, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by February 19, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. This contract represents a task order under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of parent company Cencora, Inc. The $8,016.30 fixed-price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. The award supports the DLA's mission to provide logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distributor, holds a...
- The Defense Logistics Agency awarded a $17,009.24 delivery order to AmerisourceBergen Drug Corp for Tecentriq 840 mg/14 ml vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major distribution hub for federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,962.54 to AmerisourceBergen Drug Corp for Tecentriq 840 mg/14 mL vials on December 16, 2025. This competitively awarded, firm fixed-price contract is scheduled for completion by January 8, 2026, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. Tecentriq is a specialized oncology medication used in cancer treatment protocols, reflecting the Defense Logistics Agency's role in supplying...
- The Defense Logistics Agency awarded a delivery order valued at $28,033.98 to AmerisourceBergen Drug Corp for the supply of Tecentriq (atezolizumab) 840 mg/14 mL vials on January 6, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price, non-competitive award was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...